机器人辅助双侧乳内动脉原位多支冠脉搭桥221例早期与随访结果
单中心回顾性分析2021年4月至2024年6月369例机器人辅助冠脉搭桥中221例(59.9%)采用原位双侧乳内动脉的患者,经4–6cm左胸小切口非体外循环手缝吻合。术后造影216例(97.7%)总体桥血管通畅率97.1%(545/561),术后死亡1例(0.5%),12个月生存率98.5%,主要心脑血管不良事件无生存率97.1%。
要点
- 机器人骨骼化获取双侧乳内动脉经左胸小切口完成非体外循环多支搭桥可行。
- 术后造影总体桥血管通畅率97.1%(545/561),术后死亡1例(0.5%)。
- 12个月生存率98.5%,主要心脑血管不良事件无生存率97.1%。
核心结论
- 机器人辅助原位双侧乳内动脉冠脉搭桥安全有效,可作为胸骨正中切开搭桥的微创替代方案,实现全动脉化血运重建。
研究设计与样本
- 单中心回顾性研究,2021年4月至2024年6月连续369例机器人辅助冠脉搭桥中纳入221例(59.9%)使用原位双侧乳内动脉者。
主要发现
- 221例中2支、3支、4支及以上桥血管分别为124例(56.1%)、64例(29.0%)、33例(14.9%)。
- 63例(28.5%)获取桡动脉作为第三移植物构建复合I型桥。
- 术后造影216例(97.7%),总体桥血管通畅率97.1%(545/561)。
- 术后死亡1例(0.5%),转外周体外循环1例(0.5%),无中转胸骨切开。
- 围术期输血12例(5.5%),因出血或再血管化再探查10例(4.5%)。
关键数值与推荐
- 机器人系统骨骼化获取双侧乳内动脉,经4–6cm左胸小切口非体外循环手缝远端吻合。
- 9例(4.1%)接受杂交治疗。
- 主要终点为主要心脑血管不良事件和全因死亡。
临床怎么用
- 对适合微创多支病变患者可考虑机器人辅助原位双侧乳内动脉搭桥以实现全动脉化。
- 术后造影可用于确认桥血管通畅性。
局限性
- 单中心回顾性设计,样本来自单中心连续病例,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Robotic-assisted harvesting of bilateral internal thoracic arteries offers significant advantages, and bilateral internal thoracic arteries grafting improves outcomes. This study retrospectively examined early clinical outcomes and follow-ups of patients who underwent robotic-assisted coronary artery bypass grafting with in situ bilateral internal thoracic arteries as a standardized technique in a single center. METHODS: Between April 2021 and June 2024, 369 consecutive patients underwent robotic-assisted coronary artery bypass grafting at our center, including 221 (59.9%) with in situ bilateral internal thoracic arteries. Skeletonized bilateral internal thoracic arteries harvesting was performed using a robotic system, followed by off-pump hand-sewn distal anastomoses accessed via a 4- to 6-cm left thoracotomy. A radial artery was harvested in 63 patients (28.5%) as a third conduit, forming a composite I-graft. Angiography was performed before discharge to confirm graft patency. The primary end points were major adverse cardiac/cerebrovascular events and all-cause mortality. RESULTS: Among 221 patients, the number of grafts was 2, 3, and 4 or more vessels in 124 patients (56.1%), 64 patients (29.0%), and 33 patients (14.9%), respectively. Hybrid therapy was performed in 9 (4.1%) cases. There was 1 (0.5%) conversion to peripheral cardiopulmonary bypass, no sternotomy conversions, and 1 (0.5%) postoperative death. Perioperative morbidity included 12 (5.5%) transfusions and 10 (4.5%) reexplorations for bleeding or revascularization. The postoperative graft angiography was performed on 216 patients (97.7%) and revealed an overall graft patency rate of 97.1% (545/561). The 12-month survival was 98.5%, with major adverse cardiac/cerebrovascular event-free survival at 97.1%. CONCLUSIONS: Robotic-assisted coronary artery bypass grafting with in situ bilateral internal thoracic arteries is a safe, effective, and minimally invasive alternative to sternotomy coronary artery bypass grafting, achieving total arterial revascularization and potentially improving long-term survival.
引用
- Fu Y, Hong Y, Ding T, et al. Early outcomes and follow-up of robotic-assisted multivessel coronary artery bypass with in situ bilateral internal thoracic artery: Report of 221 patients in a single center. J Thorac Cardiovasc Surg. 2025. PMID: 40532783. doi:10.1016/j.jtcvs.2025.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。